Brief: Takeda Pharmaceutical: Update On Construction Of New Plasma-Derived Therapies Manufacturing Facility In Juso, Osaka
30/09/2025 04:50
Sept 30 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T: TAKEDA PHARMACEUTICAL: UPDATE ON CONSTRUCTION OF NEW PLASMA-DERIVED THERAPIES MANUFACTURING FACILITY IN JUSO, OSAKA TAKEDA PHARMACEUTICAL: WILL REEVALUATE SCOPE OF CONSTRUCTION PLAN, TIMELINE FOR BOTH COMMENCEMENT AND COMPLETION OF CONSTRUCTION Source text: https://www.takeda.com/newsroom/statements/2025/pdts-manufacturing-facility-osaka-update/ Further company coverage: 4502.T
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)